Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP972330priorityCriticalpatent/ECSP972330A/en
Publication of ECSP972330ApublicationCriticalpatent/ECSP972330A/en
208000037265diseases, disorders, signs and symptomsDiseases0.000abstract1
Landscapes
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
La presente invención proporciona los péptidos y los compuestos que enlazan y que activan el receptor de la trombopoyetina (c-mpl o TPOR) o de otro modo actúan como un agonista de TPO. La invención tienen aplicación en los campos de la bioquímica y la química médica, y proporciona particularmente agonistas de TPO para el uso en el tratamiento de enfermedades humanas.The present invention provides the peptides and compounds that bind and activate the thrombopoietin receptor (c-mpl or TPOR) or otherwise act as a TPO agonist. The invention has application in the fields of biochemistry and medical chemistry, and particularly provides TPO agonists for use in the treatment of human diseases.
ECSP9723301997-12-041997-12-04
PEPTIDES AND COMPOUNDS THAT LINK TO A RECEIVER
ECSP972330A
(en)
compound, pharmaceutical composition, use of a compound, and, methods of imaging, monitoring the effect of treating a human or animal body with a drug to combat a condition associated with cancer and treating cancer or a related disease in a human or animal body
Method of concomitant therapeutic treatment of an individual, pharmaceutical composition, kit, use of a first agent and a second agent, and methods of preventing or treating amyloid-b-related disease, alzheimer's disease and mild cognitive impairment